NKG2C deletion is a risk factor of HIV infection
- PMID: 22074011
- PMCID: PMC3399562
- DOI: 10.1089/AID.2011.0253
NKG2C deletion is a risk factor of HIV infection
Abstract
NK cell function is important in the immune response to HIV infection. NKG2C and NKG2A are activating and inhibitory NK cell receptors, respectively, and their only known ligand, HLA-E, demonstrates increased expression in HIV infection and presents at least one HIV-derived peptide. A variation in chromosome 12 exists in which the 16-kb section of DNA encompassing the nkg2c gene is completely absent. DNA samples of 433 HIV-1-infected patients and 280 controls were genotyped by PCR, and revealed an association of the absence variation with a higher risk of HIV infection, as well as faster progression and higher pretreatment viral loads (p<0.05, respectively). Surface NKG2C expression, analyzed by FACS, on the freshly isolated lymphocytes of 20 control and 19 HIV-infected donors revealed that NKG2C expression is genotype dependent in both populations: no NKG2C expression in the -/- groups, intermediate expression in the +/- groups, and highest expression in the +/+ groups. The comparison of NKG2C and NKG2A expression in HIV and control groups (+/- and +/+ included) indicates an increased NKG2C expression on HIV patient NK cells (p<0.05) and decreased inhibitory NKG2A expression on CD8 T cells (p<0.001), and both these effects are more striking in the +/+ genotype (p<0.005). Furthermore, a positive correlation was found between HIV viral load and the proportion of NKG2C(+) NK cells. The increased expression of NKG2C in HIV patients, in combination with the genetic association of the absence variation with an increased susceptibility to HIV infection, higher HIV viral set point, and a faster progression, indicate that NKG2C is important in the defense against HIV infection and progression.
Figures




Similar articles
-
Influence of NKG2C Genotypes on HIV Susceptibility and Viral Load Set Point.J Virol. 2021 Jul 26;95(16):e0041721. doi: 10.1128/JVI.00417-21. Epub 2021 Jul 26. J Virol. 2021. PMID: 34076484 Free PMC article.
-
Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.AIDS. 2010 Jan 2;24(1):27-34. doi: 10.1097/QAD.0b013e3283328d1f. AIDS. 2010. PMID: 19910789
-
Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus.Immunol Invest. 2019 May;48(4):345-354. doi: 10.1080/08820139.2018.1538236. Epub 2018 Nov 13. Immunol Invest. 2019. PMID: 30422022
-
Cytomegalovirus: an unlikely ally in the fight against blood cancers?Clin Exp Immunol. 2018 Sep;193(3):265-274. doi: 10.1111/cei.13152. Clin Exp Immunol. 2018. PMID: 29737525 Free PMC article. Review.
-
Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.Eur J Immunol. 2013 May;43(5):1133-41. doi: 10.1002/eji.201243117. Eur J Immunol. 2013. PMID: 23552990 Review.
Cited by
-
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation.Front Immunol. 2018 Oct 23;9:2444. doi: 10.3389/fimmu.2018.02444. eCollection 2018. Front Immunol. 2018. PMID: 30405633 Free PMC article.
-
Simian Immunodeficiency Virus Infection Modulates CD94+ (KLRD1+) NK Cells in Rhesus Macaques.J Virol. 2019 Jul 30;93(16):e00731-19. doi: 10.1128/JVI.00731-19. Print 2019 Aug 15. J Virol. 2019. PMID: 31167916 Free PMC article.
-
S100A9 Tetramers, Which are Ligands of CD85j, Increase the Ability of MVAHIV-Primed NK Cells to Control HIV Infection.Front Immunol. 2015 Sep 23;6:478. doi: 10.3389/fimmu.2015.00478. eCollection 2015. Front Immunol. 2015. PMID: 26441983 Free PMC article.
-
Natural Killer Cells in Human Immunodeficiency Virus-1 Infection: Spotlight on the Impact of Human Cytomegalovirus.Front Immunol. 2017 Oct 17;8:1322. doi: 10.3389/fimmu.2017.01322. eCollection 2017. Front Immunol. 2017. PMID: 29089947 Free PMC article. Review.
-
Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort.Oncoimmunology. 2013 Mar 1;2(3):e23472. doi: 10.4161/onci.23472. Oncoimmunology. 2013. PMID: 23802087 Free PMC article.
References
-
- Jie HB. Sarvetnick N. The role of NK cells and NK cell receptors in autoimmune disease. Autoimmunity. 2004;37:147–153. - PubMed
-
- De Maria A. Fogli M. Costa P, et al. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44) Eur J Immunol. 2003;33:2410–2418. - PubMed
-
- Jacobs R. Heiken H. Schmidt RE. Mutual interference of HIV and natural killer cell-mediated immune response. Mol Immunol. 2005;42:239–249. - PubMed
-
- Nattermann J. Nischalke HD. Hofmeister V, et al. HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir Ther. 2005;10:95–107. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials